Cardinal Health, Inc.’s Stock Price Soars to $107.03, Marking a Positive Shift of +1.84%

Cardinal Health, Inc. (CAH)

107.03 USD +1.93 (+1.84%) Volume: 1.92M

“Cardinal Health, Inc.’s stock price has shown promising performance, currently standing at 107.03 USD, an impressive increase of +1.84% this trading session. With a high trading volume of 1.92M and a favorable percentage change YTD of +6.18%, CAH’s stock continues to demonstrate its strong market presence and potential for growth.”

Latest developments on Cardinal Health, Inc.

Cardinal Health Inc. (NYSE:CAH) stock has outperformed competitors in a strong trading day, standing as one of the top movers in the S&P 500. Despite the potential risk, there is an expected upside to the stock’s value. Notable transactions include Clarius Group LLC selling 337 shares, and RFG Advisory LLC and Prime Capital Investment Advisors LLC acquiring 3298 and 2911 shares respectively. Meanwhile, Mirae Asset Global Investments Co. Ltd. decreased its stock position, but still holds a $6.43 million stake in the company.

Cardinal Health, Inc. on Smartkarma

Analysts at Baptista Research on Smartkarma have published two bullish research reports on Cardinal Health. The first report, titled “Cardinal Health: Expanding Acquisitions Portfolio With Specialty Networks & Other Major Drivers,” highlights the company’s recent financial results for the second quarter of fiscal year 2024. CEO Jason Hollar and CFO Aaron Alt expressed satisfaction with the progress made, showing strong profit growth in both segments. The acquisition of Specialty Networks is seen as a strategic move to enhance Cardinal Health‘s specialty growth strategy.

In the second report, titled “Cardinal Health: The Powerhouse Behind Today’s Medical and Pharmaceutical Breakthroughs! – Major Drivers,” analysts praised Cardinal Health for delivering a solid result in the last quarter, exceeding expectations and achieving significant milestones. The company saw a 10% increase in total revenue to $54.8 billion, driven primarily by the Pharma segment. Despite flat revenue in the Medical segment, Cardinal Health surpassed expectations in Q1, showcasing its strength in the healthcare industry.

A look at Cardinal Health, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Cardinal Health, Inc. seems to have a promising long-term outlook based on its Smartkarma Smart Scores. With strong scores in Resilience and Momentum, the company appears to be well-positioned to weather challenges and maintain steady growth. Its focus on providing healthcare products and services to providers and manufacturers could contribute to its overall stability in the market.

Although Cardinal Health received lower scores in Value and Dividend, its solid scores in Growth indicate potential for expansion and development in the future. Overall, the company’s combination of services, including pharmaceutical distribution and healthcare product manufacturing, suggests a diverse and robust business model that could support its long-term success in the industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma